1D and 2D NMR spectra were recorded on a Bruker AVANCE NEO 600 (1H: 600 MHz, 13C: 150 MHz) spectrometer and JEOL ECA-600 (1H: 600 MHz, 13C: 150 MHz), using TMS as an internal standard. Chemical Shifts (δ) are presented in ppm and coupling constants (J) in Hz. HR-ESI–MS experiments were acquired using an Orbitrap Exploris 120 mass spectrometer (Thermo Fisher Scientific). Single-crystal X-ray diffraction data were acquired on a Rigaku XtaLAB Synergy-R diffractometer using Cu Ka radiation. Optical rotation value was recorded on a JASCO P-2200 polarimeter. UV spectra was obtained with a JASCO V-750 spectrophotometer. IR spectra was obtained with a JASCO FT/IR-4600 spectrophotometer. Circular dichroism was measured on JASCO J-1100 spectrometer. Powdered DIAION (Mitsubishi Chemical Co., Japan), Sephadex LH-20 (Amersham Pharmacia Biotech AB, Uppsala, Sweden), MCI gel CHP20P (Mitsubishi Chemical Co., Japan), silica gel 60 (Merck, Darmstadt, Germany) and ODS-A-HG (YMC, Kyoto, Japan, 50 µm) were used for column chromatography (CC). Silica gel GF254 plates (Merck; 0.25 mm in thickness) were used for TLC analysis.
Plant materialThe hook-bearing stems of Uncaria rhynchophylla (Miq.) Miq. were purchased from Santai Country Yuanhui Commerce and Trade Co., Ltd. in Sichuan, China. A voucher specimen (THS102306) was deposited in the herbarium of Tsumura Co., Ltd. in Japan.
Isolation of new compound 1The dried hook-bearing stems of U. rhynchophylla (14.25 kg) were percolated with 60% MeOH in H2O (101.5 L). After concentration of MeOH, the crude extract in water was partitioned with CHCl3 to obtain the CHCl3-soluble extract and the water-soluble extract. After concentration of the aqueous phase, the crude extract was subjected to DIAION HP-20 eluting successively with 60% MeOH in H2O and MeOH to obtain two fractions (60 M, DM2).
60 M was fractionated by Sephadex LH-20 CC (10–100% MeOH in H2O) to afford fractions 60M1 (61.82 g), 60M2 (21.26 g), 60M3 (115.54 g). Further separation of 60M1 (61.82 g) by ODS CC (10–100% MeOH in H2O) to obtain five fractions 60M11, 60M12, 60M13, 60M14 and 60M15. 60M13 was chromatographed on silica gel CC (CHCl3/MeOH/H2O, 40:10:1–6:4:1, v/v, successively) to obtain fractions 60M131, 60M132 and 60M133. Purification of 60M133 on ODS CC (15–16% MeCN in 50 mM NH4Ac aq.) and MCI gel CHP-20P (H2O to MeOH) afford compound 1 (68 mg). The isolation scheme of other known compounds is summarized in supplementary Fig. S13.
Spectroscopic data of rhynchophylloside L 11-O-β-D-glucopyranoside (1)Pale-brown powder; [α]D20 –99 (c = 0.1, MeOH); UV λmax (MeOH) nm (log ɛ): 247 (4.71), 253 (4.71), 310 (4.07), 321 (4.06); CD λmax (MeOH) nm (Δɛ): 224 (+ 10.47), 252 (–11.09), 294 (+ 1.02); IR (KBr) cm–1: 3398, 2923, 2877, 1635, 1604, 1574, 1454, 1250, 1076, 505; 1H and 13C NMR (600 and 150 MHz, respectively, DMSO-d6), see Table 1; positive ion HR-ESI–MS, m/z 875.2698 [M + Na]+ (calculated for C38H48N2O20Na, 875.2693).
SC-XRD analysis of 1, 2, 3, 4, 8 and 10Compound 1 (50 µg) was placed into V-type vial and added 4 µL of water. After caped vial, the suspension was dissolved by heating. The suitable single crystals of compound 1 was crystalized within a day. (C38H48N2O20)·6(H2O), M = 960.88, crystal size 0.142 × 0.013 × 0.008 mm3, orthorhombic, space group P212121, a = 6.9177(1) Å, b = 21.6692(3) Å, c = 28.7263(5) Å, V = 4306.10(11) Å 3, Z = 4, α = β = γ = 90°, density (calcd) = 1.482 g·cm–3, F(000) = 2040.0, reflections collected/unique 64,432/8602 (Rint = 0.0467), final R indices (I > 2σ (I)) R1 = 0.0476, wR2 = 0.1043, goodness of fit = 1.149, Flack parameter = 0.01(5). Crystallographic data for compound 1 have been deposited with the Cambridge Crystallographic Data Center (CCDC 2258683).
Compound 2 (50 µg) was placed into V-type vial and added 10 µL of water/ethanol/acetonitrile. After caped vial, the suspension was dissolved by heating. The suitable single crystals of compound 2 was crystalized within a day. (C38H50N2O19)·2(H2O), M = 874.83, crystal size 0.19 × 0.04 × 0.03 mm3, orthorhombic, space group P212121, a = 5.8287(2) Å, b = 19.4840(4) Å, c = 38.4044(10) Å, V = 4361.4(2) Å 3, Z = 4, α = β = γ = 90°, density (calcd) = 1.332 g·cm–3, F(000) = 1856.0, reflections collected/unique 37,841/8418 (Rint = 0.0458), final R indices (I > 2σ (I)) R1 = 0.0557, wR2 = 0.1514, goodness of fit = 1.125, Flack parameter = 0.09(7). Crystallographic data for 2 have been deposited with the Cambridge Crystallographic Data Center (CCDC 2264009).
Compound 3 (50 µg) was placed into V-type vial and added 10 µL of water/acetonitrile. After caped vial, the suspension was dissolved by heating. The suitable single crystals of compound 3 was crystalized within a day. C32H40N2O14, M = 676.66, crystal size 0.05 × 0.03 × 0.01 mm3, monoclinic, space group P21, a = 16.8414(6) Å, b = 5.9860(2) Å, c = 18.8582(6) Å, V = 1881.77(11) Å 3, Z = 2, α = γ = 90°, β = 98.187(3)°, density (calcd) = 1.194 g·cm–3, F(000) = 716.0, reflections collected/unique 23,514/7326 (Rint = 0.0507), final R indices (I > 2σ (I)) R1 = 0.0607, wR2 = 0.1521, goodness of fit = 1.019, Flack parameter = − 0.2(2). Crystallographic data for 3 have been deposited with the Cambridge Crystallographic Data Center (CCDC 2263997).
Compound 4 (50 µg) was placed into V-type vial and added 10 µL of ethanol. After caped vial, the suspension was dissolved by heating. The suitable single crystals of compound 4 was crystalized within a day. (C26H30N2O8)·(C2H6O), M = 544.59, crystal size 0.25 × 0.02 × 0.014 mm3, monoclinic, space group P21, a = 8.2300(2) Å, b = 5.85790(10) Å, c = 27.3883(6) Å, V = 1307.99(5) Å 3, Z = 2, α = γ = 90°, β = 97.862(2), density (calcd) = 1.383 g·cm–3, F(000) = 580.0, reflections collected/unique 26,131/5286 (Rint = 0.0484), final R indices (I > 2σ (I)) R1 = 0.0469, wR2 = 0.1305, goodness of fit = 1.097, Flack parameter = 0.00(10). Crystallographic data for 4 have been deposited with the Cambridge Crystallographic Data Center (CCDC 2263990).
Compound 8 was recrystallized from methanol. 2(C27H32N2O10)·8(H2O), M = 1233.22, crystal size 0.12 × 0.05 × 0.03 mm3, orthorhombic, space group P212121, a = 12.7952(4) Å, b = 19.1742(9) Å, c = 24.2979(9) Å, V = 5961.2(4) Å 3, Z = 4, α = β = γ = 90°, density (calcd) = 1.374 g·cm–3, F(000) = 2624.0, reflections collected/unique 39,208/11453 (Rint = 0.0697), final R indices (I > 2σ (I)) R1 = 0.0790, wR2 = 0.1902, goodness of fit = 1.176, Flack parameter = 0.04(11). Crystallographic data for 8 have been deposited with the Cambridge Crystallographic Data Center (CCDC 2259276).
Compound 10 was recrystallized from acetone. C21H22N2O3, M = 350.40, crystal size 0.11 × 0.06 × 0.04 mm3, orthorhombic, space group P212121, a = 7.13640(10) Å, b = 9.8793(2) Å, c = 25.4299(5) Å, V = 1792.88(6) Å 3, Z = 4, α = β = γ = 90°, density (calcd) = 1.298 g·cm–3, F(000) = 744.0, reflections collected/unique 17,419/3672 (Rint = 0.0306), final R indices (I > 2σ (I)) R1 = 0.0339, wR2 = 0.0954, goodness of fit = 0.810, Flack parameter = 0.07(9). Crystallographic data for 10 have been deposited with the Cambridge Crystallographic Data Center (CCDC 2255637).
AChE Inhibitory AssayThe AChE inhibitory activities of isolated compounds were examined based on Ellman’s method [26] using Amplite® Colorimetric Acetylcholinesterase Assay Kit (AAT Bioquest, Inc.). Briefly, 10 µL of the tested compound solution dissolved in H2O with or without 4% DMSO was mixed with 30 µL of the Assay Buffer and 10 µL of acetylcholinesterase solution (200 mU/mL in the Assay Buffer) on a 96-well microplate. Neostigmine bromide was used as a positive control. After incubation at room temperature for 20 min to facilitate binding of compounds to AChE, 50 µL of the Working Solution containing 5,5′-dithiobis(2-nitrobenzoic acid) and acetylthiocholine iodide was added. After 30 min incubation, the absorbance of each well was recorded at a wavelength of 405 nm. Following the previous report [5], the AChE inhibitory activity was calculated as follows: inhibition % = (C − S)/ (C − B) × 100% (C, the absorbance of control; S, the absorbance of sample solution; and B, the absorbance of blank).
Comments (0)